Actim Pancreatitis in NICE Medtech Innovation briefing
The National Institute for Health and Care Excellence (NICE) in UK has developed a Medtech Innovation briefing (MIB) on Actim Pancreatitis rapid test for diagnosing acute pancreatitis. The briefing once again confirms that Actim Pancreatitis is a helpful tool to diagnose or rule out acute pancreatitis.
- The innovative aspects are that it is a urine dipstick test which means the likelihood of pancreatitis can be rapidly assessed. It does not need processing in a laboratory.
- The intended place in therapy would be instead of amylase or lipase blood tests to diagnose acute pancreatitis.
- The meta-analysis showed a pooled sensitivity of 82.3% and specificity of 93.5% for diagnosing acute pancreatitis in people presenting to emergency departments with acute abdominal pain.
The full study can be read here.